NASDAQ · Financial Statements

Akoya Biosciences, Inc. (AKYA) Financial Statements

$1.29 NASDAQ: AKYA Market Cap $64.44M

Akoya Biosciences, Inc. most recently reported annual revenue of $82.0M, a net loss of $55.0M. Revenue grew at an average annual rate of 14.3% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20202021202220232024
Revenue$42.0M$55.0M$75.0M$97.0M$82.0M
Operating Profit$-11.0M$-37.0M$-66.0M$-58.0M$-47.0M
Net Profit$-17.0M$-43.0M$-71.0M$-63.0M$-55.0M
EPS$-0.45$-1.19$-1.87$-1.43$-1.12
Op Margin-27.1%-67.8%-88.4%-59.7%-57.2%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$78.0M$191.0M$176.0M$180.0M$125.0M
Total Liabilities$59.0M$70.0M$117.0M$127.0M$117.0M
Cash$17.0M$113.0M$74.0M$83.0M$12.0M
Borrowings$35.0M$33.0M$76.0M$86.0M$84.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-7.0M$-36.0M$-53.0M$-51.0M$-44.0M
Investing Cash Flow$3.0M$-10.0M$-21.0M$0$-27.0M
Financing Cash Flow$-4.0M$0$-2.0M$-2.0M$-2.0M
Net Cash Flow$5.0M$96.0M$-39.0M$9.0M$-71.0M
Free Cash Flow$-10.0M$-41.0M$-61.0M$-55.0M$-47.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA-3.68
FCF Yield-72.25%
Quick Ratio1.78
Interest Coverage-4.48
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
AKYA Overview AKYA Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.